The Asia Health Policy Program at the Walter H. Shorenstein Asia-Pacific Research Center is pleased to announce that Brian K. Chen has been awarded the %fellowship1% for 2009-2010.  Brian is currently completing his Ph.D. in Business Administration in the Business and Public Policy Group at the Haas School of Business, University of California at Berkeley.  He received a Juris Doctor from Stanford Law School in 1997, and graduated summa cum laude from Harvard College in 1992. 

As an applied economist, Brian’s research focuses on the impact of incentives in health care organizations on provider and patient behavior.  For his dissertation, Brian empirically examined how vertical integration and prohibition against self-referrals affected physician prescribing behavior.  His job market paper has been selected for presentation at the American Law and Economics Association’s Annual Meeting in 2009.

Brian comes to the Shorenstein Asia-Pacific Research Center not only with a multidisciplinary law and economics background, but also with an international perspective from having lived and worked in Taiwan, Japan, and France.  He has a particularly intimate knowledge of the Taiwanese health care system from his experience as an assistant to the hospital administrator at a medical college in Taiwan.

During his residence as a postdoctoral fellow with the Asia Health Policy Program, Brian plans to conduct empirical research on cost containment policies in Taiwan and Japan and how those policies impacted provider behavior. His work will also contribute to the program’s research activities on comparative health systems and health service delivery in the Asia-Pacific, a theme that encompasses the historical evolution of health policies; the role of the private sector and public-private partnerships; payment incentives and their impact on patients and providers; organizational innovation, contracting, and soft budget constraints; and chronic disease management and service coordination for aging populations.

The July/August issue of Health Affairs, the leading U.S.-based health policy journal, focuses on China and India. The special issue includes an article on China’s pharmaceutical policy by five contributors to Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific, a book forthcoming in 2009 from the Shorenstein Asia-Pacific Research Center series with Brookings Institution Press. Chapters on Korea and Japan by Soonman Kwon (Seoul National University) and Toshiaki Iizuka (Aoyama Gakuin University) also appear in Chinese translation in the journal Bijiao (Comparative Studies), along with an overview paper (“Pharmaceutical policy reforms to separate prescribing from dispensing in Japan and South Korea: Possible implications for China”) by Karen Eggleston, Asian Health Policy Program Director.

As Eggleston writes in the introduction to Prescribing Cultures, pharmaceuticals and their regulation play an increasingly important and often contentious role in the health care systems of the Asia Pacific.  For example, some economies such as China have extraordinarily high drug spending as a percentage of total health spending; India and a few others host thriving domestic pharmaceutical industries of global importance, while controversy surrounds patents, trade-related aspects of intellectual property (TRIPS), and pharmaceutical pricing within bilateral trade agreements (Australia-US, Republic of Korea-US); nations throughout the region struggle with appropriate regulation of drugs, from patents to evidence-based purchasing (e.g., Australia’s Pharmaceuticals Benefit Scheme) and direct-to-consumer advertising; deeply-rooted traditions of indigenous medicine are modernizing and integrating into broader health care systems; and policies to separate prescribing and dispensing re-write the professional roles of physicians and pharmacists, with modifications to accommodate cultural norms and strong economic interests. Effective prescribing and pharmaceutical use will be central to controlling infectious diseases, both old and emerging; protecting the global public good of antimicrobial effectiveness; and treating the growing burden of chronic disease in the Asia Pacific.

The forthcoming book will explore these issues in detail, through a multi-disciplinary lens. The first section of the book features chapters on pharmaceutical policy within seven selected health care systems of the Asia Pacific: South Korea, Japan, Thailand, Taiwan, Australia, India, and China. The second section focuses on the cross-cutting themes of prescribing cultures and access versus innovation. Taken as a whole, the contributions aim to provide an evidence base for policy while acknowledging the historical and cultural context that makes policies distinctive.

The Asia Health Policy Program of the Shorenstein Asia-Pacific Research Center invites scholars from multiple disciplines to join the Asia-Pacific Health Policy Forum (APHPF) by creating your own account on our website.  Your information will be saved in our online database, searchable by name, country or region of focus, discipline, and topic.  

The mission of the Asia-Pacific Health Policy Forum (APHPF) is to serve as a resource for social science research, teaching, and evidence-based policymaking about health and healthcare in the Asia-Pacific region. 

Specifically, APHPF aims to

• encourage collaboration among social scientists doing research on health policy in the Asia-Pacific region;
• serve as a resource for teaching about health and healthcare in specific countries and regions within the Asia-Pacific;
• provide analysis to inform policy, by offering a forum for rapid dissemination of policy-relevant research results, as well as by linking organizations, programs, conferences and white papers about specific health policy issues; and
• raise awareness and foster dialogue among researchers, policymakers, and business about cross-cutting themes and global challenges of health and healthcare access, quality, and cost, within the specific historical and cultural contexts of the diverse nations of the Asia-Pacific. 

We encourage all researchers with an interest in health and healthcare in the Asia-Pacific to create an account and to submit information about upcoming conferences and sessions within larger disciplinary conferences that focus on any aspect of health policy in the Asia-Pacific to the Forum coordinator, Karen Eggleston. 

There are no membership dues, as the Forum is currently supported by the Asian Health Policy Program of the Shorenstein Asia-Pacific Research Center at Stanford University.

The Asia-Pacific Health Policy Forum represents a multidisciplinary effort to build organizational linkages and work toward developing an Asia-Pacific parallel to the European Observatory on Health Systems and Policy.

With your help, the APHPF can develop into a vibrant resource and networking support for all of us seeking to understand and improve health and healthcare systems in the region.